Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/25/2021
Innovent Releases Results of a Phase 1 Clinical Study of IBI362 in Ove...
6/25/2021
NMPA Issues the List of Reference Formulations for GQCE Studies (42nd ...
6/25/2021
CDE Issues the Technical Guidelines for Pharmaceutic Change Studies of...
6/24/2021
CStone Announces Positive GAVRETO (Pralsetinib) Registrational Study D...
6/24/2021
NMPA Issues the Provisions for Registration of Licensed Pharmacists
6/24/2021
China Concludes the 5th Round of National Level VBP, Slashing Average ...
6/24/2021
NMPA Revises Packages Insert of Oxiracetam Formulations and Injectable...
6/24/2021
CDE's Annual Review of Chinese Drug Evaluation and Registration in 202...
6/24/2021
Pharmaceuticals and APIs - Biden Admin Issues 100-Day Supply Chain Rev...
6/23/2021
Online Platform Operator Medlive Tech Advances Plans for Hong Kong IPO
6/23/2021
HUTCHMED's Orpathys Conditionally Approved in China for NSCLC
6/23/2021
Innovent's Sintilimab in Combo with Chemotherapy Meets Primary Endpoin...
6/23/2021
CDE Solicits Comments on the Work Procedures for Changes During Drug R...
6/22/2021
OPKO Health to Develop and Commercialize CKD Drug RAYALDEE in Greate...
6/22/2021
BeiGene Granted Chinese Conditional Approval of Zanubrutinib r/r Walde...
6/22/2021
Innovent's Pemazyre (pemigatinib) Approved in Taiwan
6/22/2021
Hutchmed Granted Chinese Approval of Surufatinib (Sulanda) for Advance...
6/22/2021
CDE Issues the Guide to Biological Product Change Acceptance Review (I...
6/22/2021
China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hep...
6/22/2021
China Grants First CAR-T Cell Therapy Approval to Gilead JV Fosun-Kit...
6/22/2021
Big Questions Remain over China's Patent Linkage System
6/21/2021
Preparing for China's Patent Linkage System
6/21/2021
AZ/MSD Granted New Indication for Lynparza (olaparib) in China
6/21/2021
China and U.K. Initiate Drug Regulatory Cooperation Project
6/21/2021
NMPA Solicits Public Comments on Two Draft Standards for Drug Tracing ...
6/18/2021
NMPA Issues the Requirements for Post-marketing Change Items and Appli...
6/18/2021
NMPA Withdraws Approvals of 42 Domestic Drug Products
6/18/2021
NHSA Announces Outcome of Its Inventory Survey for Drugs Included in t...
6/18/2021
Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance...
6/18/2021
FibroGen and HiFiBiO Announce Transformative Partnership to Advance Ne...
Page:
126
/
719
Total number of articles:
21549
:
[First]
[<<]
[124]
[125]
[126]
[127]
[128]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit